Keywords: Roche, Fourth-quarter and full year financial results
Pfizer’s fourth-quarter net income slumps 50%
Article | 01 February 2012
Global drug behemoth Pfizer (NYSE: PFE) reported fourth-quarter 2011 net income of $1.4 billion, a year-on-year decrease of 50%, and reported diluted earnings ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
